Featured Research

from universities, journals, and other organizations

New mouse model for testing cancer drugs

Date:
July 26, 2011
Source:
Goethe University Frankfurt
Summary:
Only one in twenty cancer drugs makes its way from the laboratory to the market. The majority of new agents are only shown to be unsuitable in the later phases of clinical development which would explain the exorbitantly high development costs. A new mouse model could help researchers to recognize effects and side effects at an earlier stage.

Only one in twenty cancer drugs makes its way from the laboratory to become an approved pharmaceutical product. The majority of new agents are only shown to be unsuitable in the later phases of clinical development which would explain the exorbitantly high development costs of 500 to 600 million euros per new cancer drug. In order to recognize at an earlier stage which side effects are associated with the use of new cancer drugs, a research group under the guidance of the Goethe University has developed a new mouse model.

In cooperation with the companies Bayer Schering Pharma AG and Taconic Artemis GmbH, the researchers were the first to simulate drug-induced inhi-bition what is currently one of the most attractive target genes for new cancer drugs. They were able to demonstrate that, as a result of this, the rapid division of cancer cells was prevented while healthy cells were hardly affected.

This study has been published in the current issue of the journal, Nature Communications.

The cancer gene, polo-like kinase 1 (Plk1), which is currently the subject of intense investigation, plays a central role in cell division. However, up to now, it has not been possible with classical mouse model to investigate what would happen if this gene were to be silenced in adult animals since the latter is indispensable to embryonic de-velopment. The researchers working together with Prof. Klaus Strebhardt from the Centre for Gynecology and Obstetrics at Frankfurt's University Hospital thus devised a method of silencing the gene at any point during the lifetime of the new transgenic mouse. To this end, they expressed short RNAs with a length of 20 to 22 base pairs in the cells of the mice. These short RNAs prevent the information which is read by the cancer gene from being converted into proteins. This method known as RNA interfe-rence was further developed by the researchers into an inducible system: The design is such that the expression of Plk1-specific RNA and, in turn, the silencing of the gene is only induced by the antibiotic Doxycycline. The mice are therefore able to mature and the relevant gene is not knocked down using Doxycycline until the mice have reached adult age.

The working group supervised by Prof. Strebhardt in cooperation with Bayer Schering Pharma AG and Taconic Artemis GmbH developed the mouse model (Plk1 iKD animals). The mice were subsequently phenotypically characterized. This was done together with the Helmholtz Center in Munich, Munich's two universities as well as the universities of Gießen and Hamburg. "Surprisingly, despite the efficient knock-down of Plk1 in various tissues of the mouse following administration of Doxycycline over a six-week period, no major structural or functional anomalies were identified," reported Strebhardt. "This observation is diametrically opposed to the role of Plk1 in cancer cells of varying origins which, following the inhibition of Plk1, quickly cease dividing and go into apoptosis." In order to further verify the surprising findings in the Plk1 iKD animals, the researchers examined various primary cells in culture under controlled conditions. Just as previously in the animal experiment, Plk1 expression was inhibited through RNA interference and analyzed. In this system, too, the results of the animal experiments were confirmed: In contrast to tumor cells, healthy cells are only dependent on Plk1 expression to a minimal degree. As such, healthy cells are virtually undamaged if the Plk1 gene is silenced while the cancer cells are combated.

"Inducible RNAi-based mouse models represent an attractive way of reversibly con-trolling gene expression in order to study the targeted inactivation of genes. Our work is a feasibility study which considers whether inducible RNAi-based mouse models are suitable for predicting the toxicity of targeted cancer drugs," explained Klaus Strebhardt. "The similar results of the Plk1 knockdown in transgenic animals and cultivated primary cells have served to validate the preclinical relevance and the predictive value of the inducible iKD mouse model. This new animal model provides information on mechanism-based toxicities which could occur as a result of the pharmacological inhibition of Plk1. Our approach can be applied to many other can-cer-relevant target genes."


Story Source:

The above story is based on materials provided by Goethe University Frankfurt. Note: Materials may be edited for content and length.


Journal Reference:

  1. Monika Raab, Sven Kappel, Andrea Krämer, Mourad Sanhaji, Yves Matthess, Elisabeth Kurunci-Csacsko, Julia Calzada-Wack, Birgit Rathkolb, Jan Rozman, Thure Adler, Dirk H. Busch, Irene Esposito, Helmut Fuchs, Valérie Gailus-Durner, Martin Klingenspor, Eckhard Wolf, Nicole Sänger, Florian Prinz, Martin Hrabě de Angelis, Jost Seibler, Juping Yuan, Martin Bergmann, Rainald Knecht, Bertolt Kreft, Klaus Strebhardt. Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells. Nature Communications, 2011; 2: 395 DOI: 10.1038/ncomms1395

Cite This Page:

Goethe University Frankfurt. "New mouse model for testing cancer drugs." ScienceDaily. ScienceDaily, 26 July 2011. <www.sciencedaily.com/releases/2011/07/110719114338.htm>.
Goethe University Frankfurt. (2011, July 26). New mouse model for testing cancer drugs. ScienceDaily. Retrieved August 28, 2014 from www.sciencedaily.com/releases/2011/07/110719114338.htm
Goethe University Frankfurt. "New mouse model for testing cancer drugs." ScienceDaily. www.sciencedaily.com/releases/2011/07/110719114338.htm (accessed August 28, 2014).

Share This




More Plants & Animals News

Thursday, August 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Killer Amoeba Found in Louisiana Water System

Killer Amoeba Found in Louisiana Water System

AP (Aug. 28, 2014) — State health officials say testing has confirmed the presence of a killer amoeba in a water system serving three St. John the Baptist Parish towns. (Aug. 28) Video provided by AP
Powered by NewsLook.com
Raw: Australian Sheep Gets Long Overdue Haircut

Raw: Australian Sheep Gets Long Overdue Haircut

AP (Aug. 28, 2014) — Hoping to break the record for world's wooliest, Shaun the sheep came up 10 pounds shy with his fleece weighing over 50 pounds after being shorn for the first time in years. (Aug. 28) Video provided by AP
Powered by NewsLook.com
Minds Blown: Scientists Develop Fish That Walk On Land

Minds Blown: Scientists Develop Fish That Walk On Land

Newsy (Aug. 28, 2014) — Canadian scientists looking into the very first land animals took a fish out of water and forced it to walk. Video provided by Newsy
Powered by NewsLook.com
Fake Dogs Scare Real Geese from Wis. Park

Fake Dogs Scare Real Geese from Wis. Park

AP (Aug. 28, 2014) — Parks officials in Stevens Point, Wisconsin had a fowl problem. Canadian Geese were making a mess of a park, so officials enlisted cardboard versions of man's best friend. (Aug. 28) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins